Schrödinger
Overview
Schrödinger’s computational platform, powered by physics, is transforming the way therapeutics and materials are discovered to make innovations of the future achievable, today.
Schrödinger’s therapeutics group strives to reduce risk in drug discovery and development by selecting high-value targets with established human genetics or clinical validation, where we can solve a design challenge, and where we believe we can deliver value for patients.
Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered.